Related Experiment Videos
Claudio Rostetter1, Heinz-Theo Lübbers, Philipp Metzler
1Clinique et policlinique de chirurgie buccale et maxillofaciale, Centre de médecine dentaire, Université de Zurich, Zurich, Switzerland.
Swiss Dental Journal
|November 23, 2016
Abstract:
This script gives a pragmatic advice for dentists on pain control and anti-inflammation treatment considering current literature and state of the art of analgesic treatment. Naproxen seems to be the feasible anti-inflammatory painkiller as it has a lower cardio-vascular risk profile compared to other NSAID. The higher gastrointestinal bleeding risk can be mitigated using proton-pump inhibitors. Additionally, the duration of the drug effect of about 1215 hours allows excellent patient compliance and comfort in comparison to other NSAID.